Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy

Immunization of patients with autologous, ex vivo matured dendritic cell (DC) preparations, in order to prime antitumor T-cell responses, is the focus of intense research. Despite progress and approval of clinical approaches, significant enhancement of these personalized immunotherapies is urgently...

Descripción completa

Detalles Bibliográficos
Autores principales: Findlay, Emily Gwyer, Currie, Andrew J., Zhang, Ailiang, Ovciarikova, Jana, Young, Lisa, Stevens, Holly, McHugh, Brian J., Canel, Marta, Gray, Mohini, Milling, Simon W.F., Campbell, John D.M., Savill, John, Serrels, Alan, Davidson, Donald J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682359/
https://www.ncbi.nlm.nih.gov/pubmed/31413918
http://dx.doi.org/10.1080/2162402X.2019.1608106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682359/
https://www.ncbi.nlm.nih.gov/pubmed/31413918
http://dx.doi.org/10.1080/2162402X.2019.1608106

Ejemplares similares